-
Description
-
Why Us?
Prostate cancer is the most common cancer in men (not counting skin cancer). It is also one of the leading causes of cancer death among men.
Screening for prostate cancer begins with a blood test called a prostate specific antigen (PSA) test. This test measures the level of PSA in the blood. PSA is a substance made by the prostate. The levels of PSA in the blood can be higher in men who have prostate cancer. The PSA level may also be elevated in other conditions that affect the prostate.
Prostate cancer screening was once routinely recommended as part of regular checkups for men older than 50. That meant an average-risk man with no signs of prostate trouble would get a blood test looking for elevated levels of PSA, or prostate-specific antigen, a marker for possible prostate cancer.
Screening can help find cancers at an early stage, when they are likely to be easier to treat.
Because many factors can affect PSA levels, your doctor is the best person to interpret your PSA test results. If the PSA test is abnormal, your doctor may recommend a biopsy to find out if you have prostate cancer.
Purchase Remarks: Doctors to conduct health consultation, physical examination and result report interpretation.
Doctor Consultation
- Detailed Medical History
- Digital Rectal Examination
Lab Test :
- Cancer Marker
- PSA (Prostate)
- Urinalysis
Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.
VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.
MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.
CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity